Georgina J. Clark

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

A Clinically Relevant Mouse Model of Reduced-Intensity Conditioning for Allogeneic HLA-Identical Hematopoietic Stem Cell Transplantation.

A Clinically Relevant Mouse Model of Reduced-Intensity Conditioning for Allogeneic HLA-Identical Hematopoietic Stem Cell Transplantation.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 18, 2025

A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma.

A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 18, 2024

Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.

Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.

Journal: The Prostate
Published: June 06, 2023

CD300f signalling induces inhibitory human monocytes/macrophages.

CD300f signalling induces inhibitory human monocytes/macrophages.

Journal: Cellular immunology
Published: December 18, 2022

Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis.

Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis.

Journal: Frontiers in immunology
Published: September 28, 2021

Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer.

Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer.

Journal: Frontiers in immunology
Published: December 14, 2020

Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going.

Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going.

Journal: Journal of clinical medicine
Published: May 11, 2020

Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients.

Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients.

Journal: Blood advances
Published: May 04, 2020

Comprehensive analysis utilizing flow cytometry and immunohistochemistry reveals inflammatory changes in local endometrial and systemic dendritic cell populations in endometriosis.

Comprehensive analysis utilizing flow cytometry and immunohistochemistry reveals inflammatory changes in local endometrial and systemic dendritic cell populations in endometriosis.

Journal: Human reproduction (Oxford, England)
Published: March 16, 2020

Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?

Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?

Journal: Journal of clinical medicine
Published: January 31, 2020

Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody.

Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody.

Journal: Clinical & translational immunology
Published: January 21, 2020

Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia.

Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia.

Journal: Blood advances
Published: November 27, 2019
Showing 1-12 of 34

Last Updated: 09/26/2026